Finding drug candidates to treat cardiac and hepatic illnesses

In partnership with the startup Nintx and with funding from EMBRAPII, this project is intended to develop pharmaceutical candidates from natural products to treat cardiac and hepatic illnesses. It began in July 2022 and uses results from internal research at CNPEM, with protein targets validated in animal models. Molecules from Brazil’s biodiversity will be screened and characterized via CNPEM’s pharmaceutical discovery platform to determine activity in these cases, in order to develop new pharmaceuticals and/or phytopharmaceuticals to treat these diseases which are very prevalent but have few therapeutic options.